Dr David J Morgan

B.Sc.(Bristol), Ph.D.(Warw.)

  • BS8 1TD


Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Our laboratory is interested in examining the consequences of CD8+ T cell interactions with antigens expressed by normal tissues and cancers.  Earlier studies showed that priming of naive CD8+ T cells to become either effector CTL, or to be rendered tolerant is determined by a combination of signals mediated by professional antigen-presenting cells such as dendritic cells (DC) as well as normal and tumour cells.

We also know that altering any one of these signals dramatically shifts the balance between immune reactivity and tolerance induction.  The following projects aim to develop a deeper understanding of the cellular and molecular mechanisms that control T cell immunity to normal, infected and cancerous tissues:

  • To define the factors associated with both CD8+ T cells and tumor cells which influence the generation of effective anti-tumour responses.
  • To examine the role of the tumour microenvironment in controlling anti-tumour CD8+ T cell responses.
  • Development of novel vaccine approaches to combat human tumours.
  • Differential regulation of chronic inflammation in autoimmune disease.
  • To examine the role of dendritic cells (DC) during CD8+ T cell tolerence induction and autoimmunity to pancreatic self-antigens expressed by pancreatic islet β cell.

Fingerprint Dive into the research topics where David J Morgan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 18 Article (Academic Journal)

PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and tumor target cells within the tumor

Ambler, R., Edmunds, G., Tan, S. L., Cirillo, S., Pernes, J. I., Ruan, X., Huete-Carrasco, J., Wong, C. C. W., Lu, J., Ward, J. R. R., Toti, G., Hedges, A. J., Dovedi, S., Murphy, R. F., Morgan, D. & Wuelfing, C., 15 Sep 2020, In : Science Signaling. 13, 649, eaau4815.

Research output: Contribution to journalArticle (Academic Journal)

Open Access
  • 16 Downloads (Pure)

    A Modular Vaccine Platform Combining Self‐Assembled Peptide Cages and Immunogenic Peptides

    Morris, C., Glennie, S., Lam, H., Baum, H., Kandage, D., Williams, N., Morgan, D., Woolfson, D. & Davidson, A., 21 Feb 2019, In : Advanced Functional Materials. 29, 8, 12 p., 1807357.

    Research output: Contribution to journalArticle (Academic Journal)

    Open Access
  • 8 Citations (Scopus)
    137 Downloads (Pure)

    ICAM-1 overexpression counteracts immune-suppress cell-derived PGE2 to restore CTL function

    Basingab, F. & Morgan, D., 6 Feb 2018, In : Journal of Immunological Sciences. 2, 1, p. 37-45 9 p.

    Research output: Contribution to journalArticle (Academic Journal)

    Open Access
  • 150 Downloads (Pure)


    • 1 Participation in conference

    University of Bristol BILT Virtual Conference - Tales from the digital classroom

    Jane Williams (Speaker), David J Morgan (Participant), Joanna L Howarth (Speaker), Judith M Fox (Speaker), Martin R Van Eker (Participant), Sarah Allsop (Participant) & Charlotte A Bradbury (Participant)

    2 Jul 2020

    Activity: Participating in or organising an event typesParticipation in conference